PMID- 29185410 OWN - NLM STAT- MEDLINE DCOM- 20180402 LR - 20180402 IS - 1681-7168 (Electronic) IS - 1022-386X (Linking) VI - 27 IP - 12 DP - 2017 Dec TI - Parvovirus B19: A Rare Cause of Post-renal Transplant Anemia. PG - 785-787 AB - Parvovirus B19 infection should be contemplated as one of the differential diagnoses of persistent anemia in transplanted patients. There must be high index of suspicion of Parvovirus B19, when post-transplant patients present with refractory and severe anemia with reticulocytopenia and all the other common causes of anemia such as blood loss, adverse effects of immunosuppressant agents and graft dysfunction has been ruled out. In suspected patients, diagnosis is confirmed by serological tests (IgM and IgG), PCR from blood and/or bone marrow and by bone marrow biopsy finding of pure red cell aplasia. Intravenous immunoglobulin (IVIG) is the treatment of choice and highly rewarding. Here we are reporting two cases of post-transplant Parvovirusinfection, one in an adult lady and second in an adult man who underwent live renal transplantation recently. FAU - Ahmed, Waqar AU - Ahmed W AD - Department of Nephrology, Shaikh Zayed Hospital, Lahore. FAU - Dogar, Rizwan Ul Haq AU - Dogar RUH AD - Department of Nephrology, Shaikh Zayed Hospital, Lahore. FAU - Acharya, Sumit AU - Acharya S AD - Department of Nephrology, Shaikh Zayed Hospital, Lahore. LA - eng PT - Case Reports PT - Journal Article PL - Pakistan TA - J Coll Physicians Surg Pak JT - Journal of the College of Physicians and Surgeons--Pakistan : JCPSP JID - 9606447 RN - 0 (Immunoglobulins, Intravenous) RN - 0 (Immunosuppressive Agents) RN - WM0HAQ4WNM (Tacrolimus) SB - IM MH - Adult MH - Anemia/diagnosis/etiology/*virology MH - Female MH - Humans MH - Immunoglobulins, Intravenous/therapeutic use MH - Immunosuppressive Agents/therapeutic use MH - Kidney Transplantation/*adverse effects MH - Male MH - Parvoviridae Infections/*complications MH - Parvovirus B19, Human/*isolation & purification MH - Polymerase Chain Reaction MH - Postoperative Complications MH - Red-Cell Aplasia, Pure/*drug therapy/etiology MH - Tacrolimus/therapeutic use MH - *Transplant Recipients MH - Treatment Outcome EDAT- 2017/12/01 06:00 MHDA- 2018/04/03 06:00 CRDT- 2017/11/30 06:00 PHST- 2016/05/17 00:00 [received] PHST- 2017/08/18 00:00 [accepted] PHST- 2017/11/30 06:00 [entrez] PHST- 2017/12/01 06:00 [pubmed] PHST- 2018/04/03 06:00 [medline] AID - 040579197 [pii] PST - ppublish SO - J Coll Physicians Surg Pak. 2017 Dec;27(12):785-787.